Eximias Pharmaceutical Corporation
Latest round
- Series D
Last raised
- Mar 2004
Total raised
- $87M
Investors
- 15
About Eximias Pharmaceutical Corporation
Eximias Pharmaceuticals is a pharmaceuticals company developing late stage cancer therapeutics.
Who invested in Eximias Pharmaceutical Corporation
15 investors across 2 rounds
See all investors in Eximias Pharmaceutical Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eximias Pharmaceutical Corporation
Who invested in Eximias Pharmaceutical Corporation?
Eximias Pharmaceutical Corporation has 15 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eximias Pharmaceutical Corporation raised?
Eximias Pharmaceutical Corporation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Eximias Pharmaceutical Corporation last raise money?
Eximias Pharmaceutical Corporation's most recent round on record is a Series D, in Mar 2004.
What does Eximias Pharmaceutical Corporation do?
Eximias Pharmaceuticals is a pharmaceuticals company developing late stage cancer therapeutics.
Where is Eximias Pharmaceutical Corporation headquartered?
Eximias Pharmaceutical Corporation is headquartered in Berwyn, US.
Which VCs invest in companies like Eximias Pharmaceutical Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Eximias Pharmaceutical Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Eximias Pharmaceutical Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.